Trauma & PTSD · Texas behavioral health news
Texas leaders push for ibogaine research as veterans share stories of recovery - KCBD
PTSD & Trauma (Google News) · July 15, 2026
In plain language
Texas leaders and military veterans are advocating for more research into ibogaine, a natural plant compound that may help treat PTSD and addiction. While currently a restricted substance in the U.S., veterans have shared stories of recovery from trauma and substance use after undergoing treatment in medical settings abroad. The state of Texas has already committed $50 million to support clinical trials. These studies aim to see if the compound can safely help those who have not found success with traditional mental health programs.
AI-generated summary of the source article. Not medical advice.
Key takeaways
- Texas has invested $50 million to fund clinical trials for ibogaine research.
- Ibogaine is a psychedelic compound derived from the root bark of an African shrub.
- Veterans report that the treatment helped them overcome severe PTSD and alcohol dependence.
- The compound is currently classified as a Schedule I substance with no approved medical use in the U.S.
- Texas research institutions are expected to begin Phase 1 clinical trials with state reimbursement support.
- A recent federal executive order directed health agencies to speed up the review of psychedelic therapies.
Texas leaders push for ibogaine research as veterans share stories of recovery KCBD
Need to talk to someone in Texas? Browse Texas-licensed telehealth therapists. In crisis, call or text 988.